• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

永久性角膜移植术后眼玻璃体视网膜并发症的处理

Management of vitreoretinal complications in eyes with permanent keratoprosthesis.

作者信息

Ray Subhransu, Khan Bilal F, Dohlman Claes H, D'Amico Donald J

机构信息

Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA 02114, USA.

出版信息

Arch Ophthalmol. 2002 May;120(5):559-66. doi: 10.1001/archopht.120.5.559.

DOI:10.1001/archopht.120.5.559
PMID:12003604
Abstract

OBJECTIVES

To evaluate the spectrum and treatment of posterior segment complications in eyes that had undergone successful keratoprosthesis (KPro) placement and to determine whether transeyelid vitrectomy techniques could be effectively used in eyes otherwise vulnerable to surface exposure.

DESIGN

In the last 10 years, 110 patients received a Dohlman-Doane KPro at the Massachusetts Eye and Ear Infirmary, Boston. We evaluated 22 eyes in 18 patients that required subsequent vitreoretinal surgery to treat posterior segment complications. One surgeon using modified vitreoretinal techniques, as described below, performed all vitreoretinal procedures.

RESULTS

The posterior segment complications included 6 cases of retro-KPro membranes, 13 cases of retinal detachments, and 5 cases of isolated vitreous opacity. All 6 retro-KPro membranes were effectively removed by vitrectomy without significant complication and 3 of these patients enjoyed improvement of visual acuity of at least 5 Snellen lines. Of 13 cases of retinal detachment, 6 patients had some improvement in visual acuity, 5 showed no appreciable change, and 2 had some decline in the final visual acuity. In all 5 cases of isolated vitreous opacity, the media was effectively cleared with pars plana vitrectomy. Three patients enjoyed improvement of visual acuity of at least 3 Snellen lines. Four cases of transeyelid vitrectomy were attempted and anatomical success was achieved in all 4 and vision improved in 3 of these patients. No special surgical complications were encountered in any of the 22 eyes as a result of these modified surgical techniques.

MAIN OUTCOME MEASURES

Best preoperative and postoperative visual acuity and anatomical success were evaluated in relation to the preoperative posterior segment complication.

CONCLUSIONS

Modified vitreoretinal surgical techniques can be effectively and safely used to treat posterior segment complications in patients with KPro devices. Retro-KPro membranes and other vitreous opacities were the most amenable to treatment. Retinal complications posed a special challenge. However, all of these cases highlight that modified vitrectomy techniques can be used in eyes with permanent KPro devices. These techniques can be performed without additional risk to the eye. Additionally, we demonstrated that transeyelid vitrectomy techniques could be used effectively to manage complications in eyes with severe ocular surface disease without undue exposure of vulnerable tissues.

摘要

目的

评估成功植入角膜移植片(KPro)的眼后段并发症的范围及治疗方法,并确定经眼睑玻璃体切除术技术是否可有效用于易发生表面暴露的眼。

设计

在过去10年中,110例患者在波士顿的马萨诸塞州眼耳医院接受了多尔曼 - 多恩KPro植入术。我们评估了18例患者的22只眼,这些眼需要后续玻璃体视网膜手术来治疗后段并发症。由一名外科医生使用如下所述的改良玻璃体视网膜技术进行了所有玻璃体视网膜手术。

结果

后段并发症包括6例KPro后膜、13例视网膜脱离和5例孤立性玻璃体混浊。所有6例KPro后膜均通过玻璃体切除术有效切除,无明显并发症,其中3例患者视力至少提高了5行斯内伦视力表。13例视网膜脱离患者中,6例视力有一定改善,5例无明显变化,2例最终视力有所下降。在所有5例孤立性玻璃体混浊患者中,经扁平部玻璃体切除术有效地清除了介质。3例患者视力至少提高了3行斯内伦视力表。尝试了4例经眼睑玻璃体切除术,所有4例均获得解剖学成功,其中3例患者视力改善。由于这些改良手术技术,22只眼中任何一只均未遇到特殊手术并发症。

主要观察指标

根据术前眼后段并发症评估术前和术后最佳视力及解剖学成功情况。

结论

改良玻璃体视网膜手术技术可有效、安全地用于治疗KPro装置患者的后段并发症。KPro后膜和其他玻璃体混浊最适合治疗。视网膜并发症带来了特殊挑战。然而,所有这些病例都表明改良玻璃体切除术技术可用于永久性KPro装置的眼。这些技术可在不增加眼额外风险的情况下进行。此外,我们证明经眼睑玻璃体切除术技术可有效用于治疗严重眼表疾病眼的并发症,而不会过度暴露脆弱组织。

相似文献

1
Management of vitreoretinal complications in eyes with permanent keratoprosthesis.永久性角膜移植术后眼玻璃体视网膜并发症的处理
Arch Ophthalmol. 2002 May;120(5):559-66. doi: 10.1001/archopht.120.5.559.
2
Vitreoretinal surgery in the setting of permanent keratoprosthesis.永久性角膜移植术后的玻璃体视网膜手术。
Arch Ophthalmol. 2012 Apr;130(4):487-92. doi: 10.1001/archophthalmol.2011.1115.
3
Pars plana vitrectomy through the Boston Keratoprosthesis type 1.经 Boston 角膜假体 1 型行板层玻璃体切除术。
Eye (Lond). 2013 Jun;27(6):767-9. doi: 10.1038/eye.2013.58. Epub 2013 Apr 12.
4
RETINAL DETACHMENT IN EYES WITH BOSTON TYPE 1 KERATOPROSTHESIS: Surgical Techniques and Mid-Term Outcomes.波士顿1型人工角膜眼的视网膜脱离:手术技术与中期结果
Retina. 2022 May 1;42(5):957-966. doi: 10.1097/IAE.0000000000003389.
5
Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.波士顿Ⅰ型角膜镜联合硅油治疗前期眼球低眼压。
Cornea. 2011 Oct;30(10):1105-9. doi: 10.1097/ICO.0b013e318207f3bb.
6
Combined phacoemulsification, intraocular lens implantation, and vitrectomy for eyes with coexisting cataract and vitreoretinal pathology.联合超声乳化白内障吸除术、人工晶状体植入术及玻璃体切除术治疗合并白内障和玻璃体视网膜病变的眼。
Am J Ophthalmol. 2003 Mar;135(3):291-6. doi: 10.1016/s0002-9394(02)01972-4.
7
Wide-field vitreoretinal surgery in eyes with Boston type 1 keratoprosthesis.广角玻璃体视网膜手术在波士顿 1 型角膜镜植入眼中的应用。
Int Ophthalmol. 2022 Mar;42(3):997-1005. doi: 10.1007/s10792-021-02083-7. Epub 2021 Oct 12.
8
Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.27Gauge微创玻璃体切除术治疗眼后段疾病的疗效
Am J Ophthalmol. 2016 Jan;161:36-43.e1-2. doi: 10.1016/j.ajo.2015.09.024. Epub 2015 Sep 28.
9
Clinical complications of combined phacoemulsification and vitrectomy for eyes with coexisting cataract and vitreoretinal diseases.白内障合并玻璃体视网膜疾病患者行超声乳化白内障吸除联合玻璃体切除术的临床并发症
Eur J Ophthalmol. 2009 Jan-Feb;19(1):37-45. doi: 10.1177/112067210901900106.
10
Pars plana vitrectomy for ocular complications of Behçet's disease.用于白塞病眼部并发症的玻璃体切除术。
Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug;36(4):292-7.

引用本文的文献

1
Application of biomaterials and nanotechnology in corneal tissue engineering.生物材料和纳米技术在角膜组织工程中的应用。
J Int Med Res. 2023 Jul;51(7):3000605231190473. doi: 10.1177/03000605231190473.
2
Boston Type 1 Keratoprosthesis: Updated Perspectives.波士顿1型人工角膜:最新观点
Clin Ophthalmol. 2020 Apr 29;14:1189-1200. doi: 10.2147/OPTH.S219270. eCollection 2020.
3
Risk of Endophthalmitis in Boston Type 1 Keratoprosthesis Combined with Vitrectomy and Silicone Oil Insertion.波士顿1型人工角膜联合玻璃体切割及硅油植入术后眼内炎的风险
J Ophthalmol. 2019 Jul 25;2019:9648614. doi: 10.1155/2019/9648614. eCollection 2019.
4
Boston keratoprosthesis type 1: outcomes of the first 38 cases performed at Moorfields Eye Hospital.波士顿 1 型角膜假体:在 Moorfields 眼科医院完成的前 38 例的结果。
Eye (Lond). 2018 Jun;32(6):1087-1092. doi: 10.1038/s41433-018-0016-4. Epub 2018 Feb 14.
5
COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY.行单纯型波士顿角膜角膜镜植入术眼与联合巩膜平坦部玻璃体切除术眼的视觉和解剖学结果比较。
Retina. 2018 Sep;38 Suppl 1(Suppl 1):S125-S133. doi: 10.1097/IAE.0000000000002036.
6
Posterior Pole Retinal Detachment Due to a Macular Hole in a Patient with a Boston Keratoprosthesis.一名佩戴波士顿人工角膜患者因黄斑裂孔导致的后极部视网膜脱离
Am J Ophthalmol Case Rep. 2017 Apr;5:56-58. doi: 10.1016/j.ajoc.2016.12.001. Epub 2016 Dec 2.
7
Endophthalmitis in Boston Keratoprosthesis in a Patient with Steven-Johnson Syndrome.史蒂文斯-约翰逊综合征患者波士顿人工角膜眼内炎
Middle East Afr J Ophthalmol. 2016 Oct-Dec;23(4):329-331. doi: 10.4103/0974-9233.194095.
8
Retinal detachments after Boston Keratoprosthesis: incidence, predisposing factors, and visual outcomes.波士顿人工角膜植入术后视网膜脱离:发病率、诱发因素及视觉预后
Digit J Ophthalmol. 2015 Dec 21;21(4):1-15. doi: 10.5693/djo.01.2015.10.001. eCollection 2015.
9
Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review.波士顿人工角膜——更广泛地域应用及适应证扩展后的临床疗效——一项系统评价
Saudi J Ophthalmol. 2015 Jul-Sep;29(3):212-21. doi: 10.1016/j.sjopt.2015.02.001. Epub 2015 Feb 10.
10
Keratoprostheses for corneal blindness: a review of contemporary devices.用于角膜盲的人工角膜:当代装置综述
Clin Ophthalmol. 2015 Apr 16;9:697-720. doi: 10.2147/OPTH.S27083. eCollection 2015.